Product

OnaBoNT-A

Aliases

Botox®

Name

BOTOX

INN Name

onabotulinumtoxinA

FDA Approved

Yes

1 clinical trial

1 organization

1 indication

1 document

Indication

Upper Limb Spasticity

Clinical trial

A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport®) in Comparison With OnabotulinumtoxinA (Botox®) When Treating Adults With Upper Limb Spasticity

Status: Recruiting, Estimated PCD: 2025-06-28

Document

DailyMed Label: BOTOX Cosmetic

Organization